|
1
|
Hariharan D, Saied A and Kocher HM:
Analysis of mortality rates for pancreatic cancer across the world.
HPB (Oxford). 10:58–62. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Ward E, Brawley O and Jemal A:
Cancer statistics, 2011: the impact of eliminating socioeconomic
and racial disparities on premature cancer deaths. CA Cancer J
Clin. 61:212–236. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Johung K, Saif MW and Chang BW: Treatment
of locally advanced pancreatic cancer: the role of radiation
therapy. Int J Radiat Oncol Biol Phys. 82:508–518. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang F and Kumar P: The role of
radiotherapy in management of pancreatic cancer. J Gastrointest
Oncol. 2:157–167. 2011.PubMed/NCBI
|
|
5
|
Golub TR, Slonim DK, Tamayo P, et al:
Molecular classification of cancer: class discovery and class
prediction by gene expression monitoring. Science. 286:531–537.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ogawa K, Utsunomiya T, Mimori K, et al:
Differential gene expression profiles of radioresistant pancreatic
cancer cell lines established by fractionated irradiation. Int J
Oncol. 28:705–713. 2006.PubMed/NCBI
|
|
7
|
Moore PS, Sipos B, Orlandini S, et al:
Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of
K-ras, p53, p16 and DPC4/Smad4. Virchows Arch. 439:798–802. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gardner-Thorpe J, Ito H, Ashley SW and
Whang EE: Differential display of expressed genes in pancreatic
cancer cells. Biochem Biophys Res Commun. 293:391–395. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gupta S, Sathishkumar S and Ahmed MM:
Influence of cell cycle checkpoints and p53 function on the
toxicity of temozolomide in human pancreatic cancer cells.
Pancreatology. 10:565–579. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ohuchida K, Mizumoto K, Murakami M, et al:
Radiation to stromal fibroblasts increases invasiveness of
pancreatic cancer cells through tumor-stromal interactions. Cancer
Res. 64:3215–3222. 2004. View Article : Google Scholar
|
|
11
|
Antonov J, Goldstein DR, Oberli A, et al:
Reliable gene expression measurements from degraded RNA by
quantitative real-time PCR depend on short amplicons and a proper
normalization. Lab Invest. 85:1040–1050. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang L, Mizumoto K, Sato N, et al:
Quantitative determination of apoptotic death in cultured human
pancreatic cancer cells by propidium iodide and digitonin. Cancer
Lett. 142:129–137. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Orre LM, Pernemalm M, Lengqvist J,
Lewensohn R and Lehtiö J: Up-regulation, modification, and
translocation of S100A6 induced by exposure to ionizing radiation
revealed by proteomics profiling. Mol Cell Proteomics. 6:2122–2131.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fukuda K, Sakakura C, Miyagawa K, et al:
Differential gene expression profiles of radioresistant oesophageal
cancer cell lines established by continuous fractionated
irradiation. Br J Cancer. 91:1543–1550. 2004. View Article : Google Scholar
|
|
15
|
Hanna E, Shrieve DC, Ratanatharathorn V,
et al: A novel alternative approach for prediction of radiation
response of squamous cell carcinoma of head and neck. Cancer Res.
61:2376–2380. 2001.PubMed/NCBI
|
|
16
|
Harima Y, Togashi A, Horikoshi K, et al:
Prediction of outcome of advanced cervical cancer to
thermoradiotherapy according to expression profiles of 35 genes
selected by cDNA microarray analysis. Int J Radiat Oncol Biol Phys.
60:237–248. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tewari D, Monk BJ, Al-Ghazi MS, et al:
Gene expression profiling of in vitro radiation resistance in
cervical carcinoma: a feasibility study. Gynecol Oncol. 99:84–91.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wong YF, Sahota DS, Cheung TH, et al: Gene
expression pattern associated with radiotherapy sensitivity in
cervical cancer. Cancer J. 12:189–193. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Helland A, Johnsen H, Frøyland C, et al:
Radiation-induced effects on gene expression: an in vivo study on
breast cancer. Radiother Oncol. 80:230–235. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Otomo T, Hishii M, Arai H, Sato K and
Sasai K: Microarray analysis of temporal gene responses to ionizing
radiation in two glioblastoma cell lines: up-regulation of DNA
repair genes. J Radiat Res. 45:53–60. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jeong J, Hong SJ, Ju YJ, et al: Temporal
cDNA microarray analysis of gene expression in human hepatocellular
carcinoma upon radiation exposure. Oncol Rep. 15:33–48.
2006.PubMed/NCBI
|
|
22
|
Kumagai K, Nimura Y, Mizota A, et al:
Arpc1b gene is a candidate prediction marker for choroidal
malignant melanomas sensitive to radiotherapy. Invest Ophthalmol
Vis Sci. 47:2300–2304. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xu QY, Gao Y, Liu Y, Yang WZ and Xu XY:
Identification of differential gene expression profiles of
radioresistant lung cancer cell line established by fractionated
ionizing radiation in vitro. Chin Med J (Engl). 121:1830–1837.
2008.PubMed/NCBI
|
|
24
|
Lee YS, Oh JH, Yoon S, et al: Differential
gene expression profiles of radioresistant non-small-cell lung
cancer cell lines established by fractionated irradiation: tumor
protein p53-inducible protein 3 confers sensitivity to ionizing
radiation. Int J Radiat Oncol Biol Phys. 77:858–866. 2010.
View Article : Google Scholar
|
|
25
|
Donato R: S100: a multigenic family of
calcium-modulated proteins of the EF-hand type with intracellular
and extracellular functional roles. Int J Biochem Cell Biol.
33:637–668. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tarabykina S, Kriajevska M, Scott DJ, et
al: Heterocomplex formation between metastasis-related protein
S100A4 (Mts1) and S100A1 as revealed by the yeast two-hybrid
system. FEBS Lett. 475:187–191. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Helfman DM, Kim EJ, Lukanidin E and
Grigorian M: The metastasis associated protein S100A4: role in
tumour progression and metastasis. Br J Cancer. 92:1955–1958. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ikenaga N, Ohuchida K, Mizumoto K, et al:
S100A4 mRNA is a diagnostic and prognostic marker in pancreatic
carcinoma. J Gastrointest Surg. 13:1852–1858. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Boye K and Maelandsmo GM: S100A4 and
metastasis: a small actor playing many roles. Am J Pathol.
176:528–535. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mishra SK, Siddique HR and Saleem M:
S100A4 calcium-binding protein is key player in tumor progression
and metastasis: preclinical and clinical evidence. Cancer
Metastasis Rev. 31:163–172. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
El-Deiry WS: The role of p53 in
chemosensitivity and radiosensitivity. Oncogene. 22:7486–7495.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bristow RG, Benchimol S and Hill RP: The
p53 gene as a modifier of intrinsic radiosensitivity: implications
for radiotherapy. Radiother Oncol. 40:197–223. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Li R, Sutphin PD, Schwartz D, et al:
Mutant p53 protein expression interferes with p53-independent
apoptotic pathways. Oncogene. 16:3269–3277. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Saintigny Y, Rouillard D, Chaput B, Soussi
T and Lopez BS: Mutant p53 proteins stimulate spontaneous and
radiation-induced intrachromosomal homologous recombination
independently of the alteration of the transactivation activity and
of the G1 checkpoint. Oncogene. 18:3553–3563. 1999. View Article : Google Scholar
|
|
35
|
Cadwell C and Zambetti GP: The effects of
wild-type p53 tumor suppressor activity and mutant p53
gain-of-function on cell growth. Gene. 277:15–30. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Williams JR, Zhang Y, Zhou H, et al: A
quantitative overview of radiosensitivity of human tumor cells
across histological type and TP53 status. Int J Radiat Biol.
84:253–264. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Grigorian M, Andresen S, Tulchinsky E, et
al: Tumor suppressor p53 protein is a new target for the
metastasis-associated Mts1/S100A4 protein: functional consequences
of their interaction. J Biol Chem. 276:22699–22708. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Frazier MW, He X, Wang J, Gu Z, Cleveland
JL and Zambetti GP: Activation of c-myc gene expression by
tumor-derived p53 mutants requires a discrete C-terminal domain.
Mol Cell Biol. 18:3735–3743. 1998.PubMed/NCBI
|
|
39
|
Ahmed KM and Li JJ: NF-κB-mediated
adaptive resistance to ionizing radiation. Free Radic Biol Med.
44:1–13. 2008.
|
|
40
|
Dai Y, Lawrence TS and Xu L: Overcoming
cancer therapy resistance by targeting inhibitors of apoptosis
proteins and nuclear factor-kappa B. Am J Transl Res. 1:1–15.
2009.PubMed/NCBI
|
|
41
|
Li F and Sethi G: Targeting transcription
factor NF-κB to overcome chemoresistance and radioresistance in
cancer therapy. Biochim Biophys Acta. 1805:167–180. 2010.
|
|
42
|
Boye K, Grotterød I, Aasheim HC, Hovig E
and Maelandsmo GM: Activation of NF-κB by extracellular S100A4:
analysis of signal transduction mechanisms and identification of
target genes. Int J Cancer. 123:1301–1310. 2008.
|
